Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. These inhibitors are studied for their potential in cancer therapy due to their ability to disrupt cellular metabolism in tumor cells. The compound’s structure supports derivatization for enhanced binding affinity and selectivity in drug design. It is also employed in research settings to explore pyridine-based bioactive molecules with anti-inflammatory and neuroprotective properties.